Mometasone is a corticosteroid demonstrating anti-inflammatory properties. The precise mechanism of corticosteroids action on allergic rhinitis is not known. Corticosteroids have been shown to have a wide range of effects on multiple cell types (e.g., mast cells, eosinophils, neutrophils, macrophages, and lymphocytes) and mediators (e.g., histamine, eicosanoids, leukotrienes, and cytokines) involved in inflammation.
Metaspray Nasal Spray
(in Spray form)
Allergic Rhinitis :
Adults and children 12 years of age and older: The recommended dose for prophylaxis and treatment of the nasal symptoms of seasonal allergic rhinitis and treatment of the nasal symptoms of perennial allergic rhinitis is 2 sprays in each nostril once daily. In patients with a known seasonal allergen that precipitates nasal symptoms of seasonal allergic rhinitis, prophylaxis with Momeson Nasal Spray is recommended 2 to 4 weeks prior to the anticipated start of the pollen season.
Children 2 to 11 years of age: The recommended dose for treatment of the nasal symptoms of seasonal allergic and perennial allergic rhinitis is 1 spray in each nostril once daily
Nasal Polyps :
Adults 18 years of age and older: The recommended dose for nasal polyps is 2 sprays in each nostril twice daily. A dose of 2 sprays in each nostril once daily is also effective in some patients.
Manufacturer: Opsonin Pharma Ltd.